Korro Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Korro Bio, Inc. (KRRO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 124.94 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 1.12K shares, a 98.67% decline year-over-year.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 123.82K shares, a 292.36% increase year-over-year.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 143.86K shares, a 998.24% increase year-over-year.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 41.06K shares, a 39.17% decline year-over-year.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 300.66K shares, a 84.39% increase from fiscal 2024.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 163.05K shares, a 711.57% increase from fiscal 2023.
- Korro Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 20.09K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 124.94K shares 10-Q · filed 2026-08-06 | 268.80K shares derived: sum of 3 quarters · filed 2026-08-06 | 309.85K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 123.82K shares 10-Q · filed 2026-05-07 | 267.68K shares derived: sum of 2 quarters · filed 2026-05-07 | 308.74K shares derived: sum of 3 quarters · filed 2026-05-07 | 392.92K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 143.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 184.91K shares derived: sum of 2 quarters · filed 2026-03-12 | 269.10K shares derived: sum of 3 quarters · filed 2026-03-12 | 300.66K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 41.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 125.24K shares derived: sum of 2 quarters · filed 2025-11-12 | 156.80K shares 10-Q · filed 2025-11-12 | 169.90K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 84.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 115.74K shares 10-Q · filed 2025-08-12 | 128.84K shares derived: sum of 3 quarters · filed 2025-08-12 | 196.34K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 31.56K shares 10-Q · filed 2025-05-07 | 44.66K shares derived: sum of 2 quarters · filed 2025-05-07 | 112.15K shares derived: sum of 3 quarters · filed 2025-05-07 | 162.44K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 13.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 80.59K shares derived: sum of 2 quarters · filed 2025-03-18 | 130.88K shares derived: sum of 3 quarters · filed 2025-03-18 | 163.05K shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 67.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 117.78K shares derived: sum of 2 quarters · filed 2024-11-12 | 149.95K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 50.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 82.46K shares 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 32.17K shares 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 20.09K shares 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |